DexCom, Inc.
DXCM
$89.53
$1.882.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 249.10M | 199.50M | 267.30M | 283.80M | 179.80M |
| Total Depreciation and Amortization | 68.20M | 67.10M | 81.90M | 63.60M | 63.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.50M | 44.60M | 95.80M | 80.90M | 37.80M |
| Change in Net Operating Assets | -97.60M | 214.40M | -151.00M | 231.60M | 22.40M |
| Cash from Operations | 269.20M | 525.60M | 294.00M | 659.90M | 303.00M |
| Capital Expenditure | -84.70M | -76.60M | -101.90M | -80.50M | -94.10M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -41.20M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 455.70M | -221.90M | 408.50M | 273.30M | 30.50M |
| Cash from Investing | 329.80M | -298.50M | 306.60M | 192.80M | -63.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -1.21B | -- | -- |
| Issuance of Common Stock | 0.00 | 12.70M | 0.00 | 13.90M | 0.00 |
| Repurchase of Common Stock | -605.40M | -35.80M | -312.80M | -187.20M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.90M | -1.90M | -1.90M | -1.70M | -1.70M |
| Cash from Financing | -607.30M | -25.00M | -1.52B | -175.00M | -1.70M |
| Foreign Exchange rate Adjustments | -4.90M | -2.80M | 3.80M | -1.10M | 16.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.20M | 199.30M | -917.80M | 676.60M | 254.20M |